Pharmexa appoints new Chief Executive Officer and implements further cost-saving measures
Change in management Pharmexa's Board of Directors decided today to appoint Achim Kaufhold as its new Chief Executive Officer, effective 2 July, 2008. Achim Kaufhold, M.D, Ph.D, was recently hired as Pharmexa's Executive Vice President, Chief Scientific Officer & Chief Medical Officer. Prior to joining Pharmexa, Achim Kaufhold held a number of executive positions in research, product & business development at GlaxoSmithKline, Berna Biotech (now a Crucell company) and Chiron (now part of Novartis). He succeeds Jakob Schmidt who will join the board of directors contingent on shareholder approval at the next general assembly.
Most read news
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.